IDH1/IDH2 mutations predict survival in glioma and AML

被引：0
|
作者：
Hegi, M. [1 ]
机构：
[1] CHUV, Lausanne, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72597-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [41] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
    Brittany Knick Ragon
    Courtney D. DiNardo
    Current Hematologic Malignancy Reports, 2017, 12 : 537 - 546
  • [42] Rapid Determination of IDH1 and IDH2 Mutation Status in AML and Glioma Using a Microfluidic Detection System
    Magliocco, A.
    Esguerra, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S163 - S163
  • [43] Inhibitors of mutant IDH1 and IDH2
    Pamela Feliciano
    Nature Genetics, 2013, 45 (5) : 477 - 477
  • [44] Profiling the effects of IDH1 and IDH2 mutants on the glioma cell metabolome
    Yan, Hai
    Reitman, Zachary J.
    Jin, Genglin
    Spasojevic, Ivan
    He, Yiping
    Bigner, Dare D.
    Karoly, Edward D.
    Yang, Jian
    Kinzler, Kenneth W.
    Vogelstein, Bert
    CANCER RESEARCH, 2011, 71
  • [45] IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients
    Stancheva, Gergana
    Goranova, Teodora
    Laleva, Maria
    Kamenova, Margarita
    Mitkova, Atanaska
    Velinov, Nikolay
    Poptodorov, George
    Mitev, Vanio
    Kaneva, Radka
    Gabrovsky, Nikolay
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [46] IDH1 (BUT NOT IDH2) MUTATIONS CAUSE INFERIOR OUTCOME IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETICS
    Markova, J.
    Michkova, P.
    Salek, C.
    Brezinova, J.
    Maaloufova, J. Soukupova
    Soukup, P.
    Cetkovsky, P.
    Michalova, K.
    Schwarz, J.
    HAEMATOLOGICA, 2015, 100 : 371 - 371
  • [47] PROGNOSTIC IMPACT OF IDH1 AND IDH2 MUTATIONS IN LOW AND INTERMEDIATE RISK AML: A MULTICENTER RETROSPECTIVE STUDY
    Lessi, F.
    Riva, M.
    Gottardi, M.
    Mosna, F.
    Luca, B.
    Minotto, C.
    Bertorelle, R.
    Semenzato, G.
    HAEMATOLOGICA, 2017, 102 : 382 - 382
  • [48] Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups
    F Damm
    F Thol
    I Hollink
    M Zimmermann
    K Reinhardt
    M M van den Heuvel-Eibrink
    C M Zwaan
    V de Haas
    U Creutzig
    J-H Klusmann
    J Krauter
    M Heuser
    A Ganser
    D Reinhardt
    C Thiede
    Leukemia, 2011, 25 : 1704 - 1710
  • [49] PREVALENCE AND PROGNOSTIC IMPACT OF IDH1 AND IDH2 MUTATIONS AMONG CYTOGENETICALLY NORMAL AML EGYPTIAN PATIENTS
    Aref, S.
    El-Ghonemy, M.
    El Baiomy, M.
    HAEMATOLOGICA, 2015, 100 : 656 - 656
  • [50] IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis
    Essia Saiji
    Fabienne Gumy Pause
    Pierre Lascombes
    Christelle Cerato Biderbost
    Nathalie Lin Marq
    Margaret Berczy
    Laura Merlini
    Anne-Laure Rougemont
    Virchows Archiv, 2019, 475 : 625 - 636
12345